Pharmaceuticals by one-year price change
How far the share price has moved over the last 52 weeks.
Erasca leads the 61 pharmaceuticals ranked by one-year price change, at +403%, ahead of Spyre Therapeutics (+286%) and Oruka Therapeutics (+241%). Figures as of 18 Nov 2026, 14:39 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Erasca+403%
- Median
- +26.9%
- Combined market value
- TRY 259.5T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | 1 year ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ErascaERAS · Health Care | +403% | TRY 244.5B | TRY 696.55 | 0.58% down | 403% up | ||
| 2 | Spyre TherapeuticsSYRE · Health Care | +286% | TRY 454.6B | TRY 4,786.29 | 1.16% up | 286% up | ||
| 3 | Oruka TherapeuticsORKA · Health Care | +241% | TRY 337.8B | TRY 4,980.48 | 2.52% up | 241% up | ||
| 4 | VeradermicsMANE · Health Care | +233% | TRY 269.1B | TRY 6,378.61 | 0.46% up | 233% up | ||
| 5 | Definium TherapeuticsDFTX · Health Care | +169% | TRY 203.5B | TRY 1,486.40 | 0.31% up | 169% up | ||
| 6 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | +126% | TRY 381.8B | TRY 4,859.47 | 1.30% up | 126% up | ||
| 7 | Dianthus TherapeuticsDNTH · Health Care | +113% | TRY 247.9B | TRY 4,402.71 | 0.36% up | 113% up | ||
| 8 | TG TherapeuticsTGTX · Health Care | +107% | TRY 483.9B | TRY 3,201.48 | 1.22% up | 107% up | ||
| 9 | ViatrisVTRS · Health Care | +95.5% | TRY 1.19T | TRY 1,038.77 | 0.71% up | 96% up | ||
| 10 | Roivant SciencesROIV · Health Care | +90.3% | TRY 1.42T | TRY 1,959.89 | 0.38% up | 90% up | ||
| 11 | Edgewise TherapeuticsEWTX · Health Care | +88.2% | TRY 233.2B | TRY 2,130.24 | 0.46% up | 88% up | ||
| 12 | Amneal PharmaceuticalsAMRX · Health Care | +83.3% | TRY 376.2B | TRY 1,079.73 | 1.36% up | 83% up | ||
| 13 | Royalty PharmaRPRX · Health Care | +77.7% | TRY 2T | TRY 3,472.14 | 0.23% up | 78% up | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | +74.4% | TRY 2.52T | TRY 2,159.19 | 0.47% up | 74% up | ||
| 15 | GenmabGMAB · Health Care | +70.0% | TRY 1.62T | TRY 2,619.23 | 0.06% down | 70% up | ||
| 16 | Praxis Precision MedicinesPRAX · Health Care | +61.1% | TRY 430.3B | TRY 15,395.12 | 0.06% up | 61% up | ||
| 17 | AlkermesALKS · Health Care | +58.4% | TRY 391.5B | TRY 2,329.97 | 1.64% up | 58% up | ||
| 18 | Takeda PharmaceuticalTAK · Health Care | +53.6% | TRY 3.47T | TRY 1,085.67 | 0.55% down | 54% up | ||
| 19 | Merck & CoMRK · Health Care | +50.8% | TRY 17.48T | TRY 7,092.05 | 1.95% down | 51% up | ||
| 20 | Protagonist TherapeuticsPTGX · Health Care | +46.4% | TRY 414.6B | TRY 6,352.64 | 1.03% up | 46% up | ||
| 21 | Travere TherapeuticsTVTX · Health Care | +44.2% | TRY 246.8B | TRY 2,571.32 | 0.23% down | 44% up | ||
| 22 | Ligand PharmaceuticalsLGND · Health Care | +42.6% | TRY 299.9B | TRY 14,993.64 | 1.18% up | 43% up | ||
| 23 | Johnson & JohnsonJNJ · Health Care | +37.6% | TRY 33.8T | TRY 14,040.87 | 0.16% down | 38% up | ||
| 24 | Jazz PharmaceuticalsJAZZ · Health Care | +36.7% | TRY 777.9B | TRY 12,119.44 | 0.18% down | 37% up | ||
| 25 | Regeneron PharmaceuticalsREGN · Health Care | +36.3% | TRY 5.03T | TRY 48,665.89 | 0.74% up | 36% up | ||
| 26 | Eli LillyLLY · Health Care | +34.9% | TRY 63.65T | TRY 71,461.24 | 0.10% up | 35% up | ||
| 27 | Bristol-Myers SquibbBMY · Health Care | +34.0% | TRY 6.28T | TRY 3,073.17 | 0.73% down | 34% up | ||
| 28 | Belite BioBLTE · Health Care | +31.0% | TRY 323.1B | TRY 7,955.05 | 0.00% | 31% up | ||
| 29 | Mirum PharmaceuticalsMIRM · Health Care | +30.5% | TRY 301.4B | TRY 4,616.57 | 0.46% down | 31% up | ||
| 30 | Ascendis PharmaASND · Health Care | +27.8% | TRY 896.7B | TRY 13,670.65 | 0.06% down | 28% up | ||
| 31 | Vertex PharmaceuticalsVRTX · Health Care | +26.9% | TRY 6.85T | TRY 27,004.38 | 0.22% up | 27% up | ||
| 32 | AbbVieABBV · Health Care | +25.7% | TRY 26T | TRY 14,709.17 | 0.42% down | 26% up | ||
| 33 | NovartisNVS · Health Care | +25.0% | TRY 15.01T | TRY 7,946.98 | 1.01% down | 25% up | ||
| 34 | United TherapeuticsUTHR · Health Care | +22.6% | TRY 1.26T | TRY 29,468.52 | 0.03% up | 23% up | ||
| 35 | Elanco Animal HealthELAN · Health Care | +20.5% | TRY 665.8B | TRY 1,332.06 | 2.17% up | 20% up | ||
| 36 | BridgeBio PharmaBBIO · Health Care | +17.2% | TRY 756.7B | TRY 3,884.72 | 0.29% up | 17% up | ||
| 37 | BeOne MedicinesONC · Health Care | +16.8% | TRY 2.36T | TRY 20,662.34 | 0.87% down | 17% up | ||
| 38 | PfizerPFE · Health Care | +14.4% | TRY 8.18T | TRY 1,435.71 | 0.02% up | 14% up | ||
| 39 | Rhythm PharmaceuticalsRYTM · Health Care | +13.0% | TRY 405.3B | TRY 5,846.24 | 0.60% down | 13% up | ||
| 40 | BioMarin PharmaceuticalBMRN · Health Care | +11.3% | TRY 576.2B | TRY 2,974.82 | 0.80% up | 11% up | ||
| 41 | Arrowhead PharmaceuticalsARWR · Health Care | +10.3% | TRY 307.2B | TRY 2,173.11 | 0.22% up | 10% up | ||
| 42 | GSKGSK · Health Care | +6.26% | TRY 4.98T | TRY 2,482.55 | 0.01% down | 6% up | ||
| 43 | Dr. Reddy's LaboratoriesRDY · Health Care | +5.27% | TRY 628.2B | TRY 753.54 | 0.95% up | 5% up | ||
| 44 | AstraZenecaAZN · Health Care | +2.41% | TRY 14.15T | TRY 9,122.93 | 0.74% down | 2% up | ||
| 45 | GrifolsGRFS · Health Care | +1.41% | TRY 296.2B | TRY 435.28 | 0.00% | 1% up | ||
| 46 | SanofiSNY · Health Care | -4.08% | TRY 5.76T | TRY 2,398.32 | 0.04% up | 4% down | ||
| 47 | Axsome TherapeuticsAXSM · Health Care | -7.37% | TRY 362.5B | TRY 6,890.81 | 0.49% up | 7% down | ||
| 48 | Corcept TherapeuticsCORT · Health Care | -7.92% | TRY 390B | TRY 3,563.68 | 0.83% up | 8% down | ||
| 49 | Novo NordiskNVO · Health Care | -16.9% | TRY 8.97T | TRY 2,035.42 | 0.86% down | 17% down | ||
| 50 | Abbott LaboratoriesABT · Health Care | -17.0% | TRY 9.15T | TRY 5,281.09 | 0.05% down | 17% down | ||
| 51 | PTC TherapeuticsPTCT · Health Care | -20.2% | TRY 253.8B | TRY 3,037.61 | 0.22% down | 20% down | ||
| 52 | CytokineticsCYTK · Health Care | -20.3% | TRY 365.7B | TRY 2,625.54 | 0.78% up | 20% down | ||
| 53 | Cogent BiosciencesCOGT · Health Care | -20.3% | TRY 248.3B | TRY 1,426.88 | 1.58% up | 20% down | ||
| 54 | Madrigal PharmaceuticalsMDGL · Health Care | -24.0% | TRY 492.7B | TRY 21,208.07 | 0.36% down | 24% down | ||
| 55 | ABIVAXABVX · Health Care | -27.3% | TRY 367.2B | TRY 4,194.40 | 1.29% up | 27% down | ||
| 56 | ZoetisZTS · Health Care | -28.7% | TRY 1.72T | TRY 4,240.30 | 0.71% up | 29% down | ||
| 57 | Summit TherapeuticsSMMT · Health Care | -35.6% | TRY 425.8B | TRY 532.37 | 1.08% down | 36% down | ||
| 58 | InsmedINSM · Health Care | -40.1% | TRY 1.35T | TRY 6,157.44 | 0.18% up | 40% down | ||
| 59 | Legend BiotechLEGN · Health Care | -42.5% | TRY 164.3B | TRY 846.85 | 4.22% up | 42% down | ||
| 60 | Ionis PharmaceuticalsIONS · Health Care | -63.6% | TRY 231B | TRY 1,387.04 | 2.00% up | 64% down | ||
| 61 | Alnylam PharmaceuticalsALNY · Health Care | -66.0% | TRY 1.06T | TRY 7,888.97 | 0.06% down | 66% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 50.4378 TRY).
Questions and answers
Which pharmaceuticals rank first by one-year price change?
Erasca (+403%), Spyre Therapeutics (+286%) and Oruka Therapeutics (+241%) are the top three of the 61 pharmaceuticals ranked by one-year price change as of 18 Nov 2026, 14:39 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by one-year price change.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by one-year price change have a combined market value of TRY 259.5T as of 18 Nov 2026, 14:39 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Pharmaceuticals by one-year price change”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.